Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07513649
PHASE1
A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R
Sponsor: Dong-A ST Co., Ltd.
View on ClinicalTrials.gov
Summary
A study to evaluate the bioequivalence of DA-5230 compared to DA-5230-R
Official title: An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Bioequivalence of DA-5230 With DA-5230-R in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-04
Completion Date
2026-05
Last Updated
2026-04-07
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
DA-5230
Test drug
DRUG
DA-5230-R
Reference drug